Anavex Life Sciences Corp.

LSE:0HFR.LHealthcare

——At close · Market cap —

0HFR.L · Ratios · TradingHolo

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Return on equity	−96.5%	−25.1%	−33.7%	−33.5%	−35.8%	−48.9%	−48.9%	+0.0 pts
Return on assets	−76.1%	−23.5%	−31.4%	−30.8%	−31.7%	−44.7%	−44.7%	+0.0 pts
Return on capital employed	−114.1%	−27.8%	−35.8%	−39.3%	−44.0%	−52.1%	—	—
Debt / equity	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—
Debt / assets	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—
Interest coverage	0.0×	0.0×	0.0×	−57.8×	0.0×	0.0×	—	—
Current ratio	4.7×	15.0×	15.0×	12.3×	8.9×	20.3×	20.3×	+0.0%
Quick ratio	4.7×	15.0×	15.0×	12.3×	8.9×	20.3×	—	—
Cash ratio	4.0×	14.1×	14.6×	12.0×	8.6×	20.3×	20.3×	+0.0%
Asset turnover	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Receivables turnover	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 30 Sep 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.